A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02672501

Recruitment Status : Unknown

Verified February 2016 by Shanghai GeneChem Co., Ltd..
Recruitment status was: Recruiting

First Posted : February 3, 2016

Last Update Posted : February 3, 2016

Sponsor:

Information provided by (Responsible Party):

Shanghai GeneChem Co., Ltd.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	June 2018
Estimated Study Completion Date :	December 2019

To Top